Application of the rainbow trout derived intestinal cell line (RTgutGC) for ecotoxicological studies: molecular and cellular responses following exposure to copper.

There is an acknowledged need for in vitro fish intestinal model to help understand dietary exposure to chemicals in the aquatic environment. The presence and use of such models is however largely restrictive due to technical difficulties in the culturing of enterocytes in general and the availability of appropriate established cell lines in particular. In this study, the rainbow trout (Oncorhynchus mykiss) intestinal derived cell line (RTgutGC) was used as a surrogate for the "gut sac" method. To facilitate comparison, RTgutGC cells were grown as monolayers (double-seeded) on permeable Transwell supports leading to a two-compartment intestinal model consisting of polarised epithelium. This two-compartment model divides the system into an upper apical (lumen) and a lower basolateral (portal blood) compartment. In our studies, these cells stained weakly for mucosubstances, expressed the tight junction protein ZO-1 in addition to E-cadherin and revealed the presence of polarised epithelium in addition to microvilli protrusions. The cells also revealed a comparable transepithelial electrical resistance (TEER) to the in vivo situation. Importantly, the cell line tolerated apical saline (1:1 ratio) thus mimicking the intact organ to allow assessment of uptake of compounds across the intestine. Following an exposure over 72 h, our study demonstrated that the RTgutGC cell line under sub-lethal concentrations of copper sulphate (Cu) and modified saline solutions demonstrated uptake of the metal with saturation levels comparable to short term ex situ gut sac preparations. Gene expression analysis revealed no significant influence of pH or time on mRNA expression levels of key stress related genes (i.e. CYP3A, GST, mtA, Pgp and SOD) in the Transwell model. However, significant positive correlations were found between all genes investigated suggesting a co-operative relationship amongst the genes studied. When the outlined characteristics of the cell line are combined with the division of compartments, the RTgutGC double seeded model represents a potential animal replacement model for ecotoxicological studies. Overall, this model could be used to study the effects and predict aquatic gastrointestinal permeability of metals and other environmentally relevant contaminants in a cost effective and high throughput manner

DNA damage in B and T lymphocytes of farmers during one pesticide spraying season

Purpose The effect of one pesticide spraying seasonon DNA damage was measured on B and T lymphocytesamong open-field farmers and controls.Methods At least two peripheral blood samples were collectedfrom each individual: one in a period without anypesticide application, several weeks after the last use (January,at period P0), and another in the intensive pesticidespraying period (May or June, at period P4). DNA damagewas studied by alkaline comet assay on isolated B or Tlymphocytes.Results Longitudinal comparison of DNA damageobserved at both P0 and P4 periods revealed a statisticallysignificant genotoxic effect of the pesticide spraying seasonin both B (P = 0.02) and T lymphocytes (P = 0.02) in exposed farmers. In contrast, non-farmers did not showany significant modifications. DNA damage levels in Band T lymphocytes were significantly higher in farmersthan in non-farmers during the P4 period (P = 0.003 andP = 0.001 for B and T lymphocytes, respectively) but notduring the P0 period. The seasonal effect observed amongfarmers was not correlated with either total farm area, farmarea devoted to crops or recent solar exposure. On average,farmers used pesticides for 21 days between P0 and P4.Between the two time points studied, there was a tendencyfor a potential effect of the number of days of fungicidetreatments (r2 = 0.43; P = 0.11) on T lymphocyte DNAdamage.Conclusions A genotoxic effect was found in lymphocytesof farmers exposed to pesticides, suggesting in particularthe possible implication of fungicides

Assignment of phosphorus-31 chemical shifts to isomers of 2,3-dialkoxy-λ3\lambda 3-diazadiphosphetidines. Crystal and molecular structure of trans−[PhNP(OCH2CF3)]2-[PhNP(OCH_2CF_3)]2

Geometrical isomers of $\lambda$3-diazadiphosphetidines show large differences in their 31P chem. shifts. Trifluoroethoxylation of cis-$(PhNPCl)_2$ gives only the low-field isomer initially, for which the crystal structure is detd. The alkoxy groups are trans to each other. On standing in soln., trans-$[PhNP(OCH_2CF_3)]2$transforms slowly and almost completely into its cis analog with a high-field 31P chem. shift

Genotoxicity evaluation of medical devices: A regulatory perspective

This review critically evaluates our current regulatory understanding of genotoxicity testing and risk assessment of medical devices. Genotoxicity risk assessment of these devices begins with the evaluation of materials of construction, manufacturing additives and all residual materials for potential to induce DNA damage. This is followed by extractable and/or leachable (E&L) studies to understand the worst case and/or clinical exposures, coupled with risk assessment of extractables or leachables. The TTC (Threshold of Toxicological Concern) approach is used to define acceptable levels of genotoxic chemicals, when identified. Where appropriate, in silico predictions may be used to evaluate the genotoxic potentials of identifiable chemicals with limited toxicological data and above the levels defined by TTC. Devices that could not be supported by E&L studies are evaluated by in vitro genotoxicity studies conducted in accordance with ISO10993-3 and 33. Certain endpoints such as ‘site of contact genotoxicity’ that are specific for certain classes of medical devices are currently not addressed in the current standards. The review also illustrates the potential uses of recent advances to achieve the goal of robust genotoxicity assessment of medical devices which are being increasingly used for health benefits. The review also highlights the gaps for genotoxicity risk assessment of medical devices and suggests possible approaches to address them taking into consideration the recent advances in genotoxicity testing including their potential uses in biocompatibility assessment